九州通品牌怎么样 申请店铺

我要投票 九州通在减肥药行业中的票数:822 更新时间:2025-12-29
九州通是哪个国家的品牌?「九州通」是 九州通医药集团股份有限公司 旗下著名品牌。该品牌发源于湖北,由创始人刘宝林在2000期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力九州通品牌出海!将品牌入驻外推网,定制九州通品牌推广信息,可以显著提高九州通产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

九州通怎么样

九州通医药集团股份有限公司是一家以药品、医疗器械、生物制品、保健品等产品批发、零售连锁、药品生产与研发及有关增值服务为核心业务的大型企业集团。

截至2012年12月31日,九州通医药集团拥有总资产148.04亿元,员工9,148人,下属公司80余家,直营和加盟的零售连锁药店875家。2012年,九州通医药集团实现营业收入295.08亿元,上缴税收近5亿元。

九州通医药集团拥有完善的品种结构和丰富的客户资源,经营品规达160,000多个,上游供货商5,600家,下游客户70,000多家,取得了国内131种药品的全国或区域总经销或总代理资格。至今为止,九州通医药集团已在全国22个省会城市设立了22家省级子公司(大型医药物流中心)、在29个地级市设立了29家地级公司(地区医药物流配送中心)及400多个终端配送点,形成了覆盖全国大部分县级行政区域的物流配送网络。

打造企业核心竞争力,九州通医药集团秉持“技术让服务更卓越”的理念,致力于现代物流技术和信息技术的开发和应用。目前,九州通医药集团是国内唯一具备独立整合物流规划、物流实施、系统集成能力的医药分销企业,并取得了20多项自主知识产权,在现代物流技术和信息技术方面处于国内领先、国际一流的地位,是国内医药行业唯一获得“中国物流改革开放30年旗帜企业”称号的企业。

九州通医药集团具备向上下游客户提供需求解决方案及增值服务的能力,并逐渐将技术增值服务延伸到了上下游产业链,形成了独具特色的物流管理、供应链管理、医院管理三大产品线,可以满足客户对技术的最高要求。

近年来,九州通医药集团曾获得“国家5A级物流企业”、“湖北省最具影响力民营企业”、“湖北省守合同重信用企业”、“中国社会责任感优秀企业”、“全国非公有制企业双强百佳党组织”等多项荣誉。

未来,九州通医药集团将顺应医药市场变革,继续坚持以医药分销为核心业务,以医院纯销、中药材、医疗器械、零售连锁为战略业务,以物流技术营销、电子商务、国际贸易、原料药等为新兴业务的业务组合战略;扩大和完善医药营销网络布局,不断为医药健康产业提供高性价比服务,努力将九州通打造成为中国医药健康产业最佳服务商。

JIUZHOUTONG Pharmaceutical Group Co., Ltd. is a large-scale enterprise group with the core business of wholesale, retail chain, drug production and R & D and related value-added services of drugs, medical devices, biological products, health products and other products. As of December 31, 2012, JIUZHOUTONG Pharmaceutical Group has a total assets of 14.804 billion yuan, 9148 employees, more than 80 subordinate companies, 875 retail chain drugstores directly operated and joined. In 2012, JIUZHOUTONG Pharmaceutical Group achieved an operating revenue of 29.508 billion yuan and turned in tax revenue of nearly 500 million yuan. JIUZHOUTONG Pharmaceutical Group has a complete variety structure and rich customer resources. It operates more than 160000 products, 5600 upstream suppliers and 70000 downstream customers. It has obtained the qualification of national or regional general distribution or general agent of 131 kinds of drugs in China. So far, JIUZHOUTONG Pharmaceutical Group has set up 22 provincial subsidiaries (large pharmaceutical logistics centers) in 22 provincial capitals, 29 prefecture level companies (regional pharmaceutical logistics distribution centers) and more than 400 terminal distribution points in 29 prefecture level cities, forming a logistics distribution network covering most county-level administrative regions of the country. To build the core competitiveness of the enterprise, JIUZHOUTONG Pharmaceutical Group adheres to the concept of "technology makes service more excellent", and is committed to the development and application of modern logistics technology and information technology. At present, JIUZHOUTONG Pharmaceutical Group is the only pharmaceutical distribution enterprise in China that has the ability to independently integrate logistics planning, logistics implementation and system integration, and has obtained more than 20 independent intellectual property rights. It is in the leading position in modern logistics technology and information technology in China and the first-class position in the world. It is the only one in the domestic pharmaceutical industry that has won the title of "30 years banner enterprise of China's logistics reform and opening up" Enterprises. JIUZHOUTONG Pharmaceutical Group has the ability to provide demand solutions and value-added services to upstream and downstream customers, and gradually extends technology value-added services to the upstream and downstream industrial chains, forming a unique logistics management, supply chain management, hospital management three product lines, which can meet the highest requirements of customers for technology. In recent years, JIUZHOUTONG Pharmaceutical Group has won many honors, such as "national 5A level logistics enterprise", "the most influential private enterprise in Hubei Province", "Hubei Province contract abiding and trustworthy enterprise", "China's outstanding enterprise of social responsibility", "national top 100 Party organizations of non-public enterprises". In the future, JIUZHOUTONG Pharmaceutical Group will continue to adhere to the core business of pharmaceutical distribution, the strategic business of hospital pure sales, Chinese herbal medicine, medical devices, retail chain, the business combination strategy of logistics technology marketing, e-commerce, international trade, API and other emerging businesses, expand and improve the layout of pharmaceutical marketing network, and continue to serve the medical health The industry provides cost-effective services and strives to build Jiuzhoutong into the best service provider in China's pharmaceutical and health industry.

本文链接: https://brand.waitui.com/02808d9a5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

国家电网成立冀北新型电力系统研究院公司

36氪获悉,爱企查App显示,近日,国网冀北新型电力系统研究院(河北)有限公司成立,法定代表人为张东晖,注册资本4000万元人民币,经营范围包括大数据服务、数据处理服务、工业互联网数据服务、云计算装备技术服务、人工智能公共服务平台技术咨询服务等。股权穿透图显示,该公司由国家电网有限公司间接全资持股。

45分钟前

苏丹2025年产黄金70吨,产量超预期10%以上

苏丹矿产资源公司12月28日发布声明说,2025年该国黄金产量达70吨,超过预定目标13%。苏丹矿业部长努尔·达伊姆·塔哈在声明中说,2025年苏丹矿业公共收入总额约为1.087万亿苏丹镑(1美元约合3400苏丹镑),期待在2026年将新的国家项目纳入矿业发展规划。(新华社)

45分钟前

A股三大指数午间休盘涨跌不一,化纤板块领涨

36氪获悉,A股三大指数午间休盘涨跌不一,沪指涨0.31%,深成指涨0.03%,创业板指跌0.32%;化纤、汽车零部件、航天军工板块领涨,吉林碳谷涨超16%,超捷股份涨超15%,中国卫星涨超8%;零售、电力、制药板块走弱,漱玉平民跌超17%,皖能电力跌超6%,珍宝岛跌超5%。

45分钟前

半日主力资金加仓电子、国防军工股,抛售电力设备股

主力资金早间净流入电子、国防军工、机械设备、计算机、汽车、基础化工等板块,净流出电力设备、公用事业、食品饮料、商贸零售、医药生物、交通运输等板块。具体到个股来看,寒武纪-U、拓维信息、海格通信获净流入29.21亿元、21.43亿元、17.70亿元。净流出方面,紫金矿业、阳光电源、天际股份遭抛售10.68亿元、8.14亿元、8.06亿元。(第一财经)

45分钟前

美政府启动对大型企业涉“多元化”举措的调查

美国特朗普政府已启动针对大型企业涉及“多元化、平等、包容”(DEI)项目的调查。据了解,美国司法部正就企业在招聘与晋升过程中推行DEI举措的合法性进行审查。司法部副部长托德·布兰奇已向部门内部发送备忘录,说明此次调查的相关情况。调查要求审查政府承包商在招聘及晋升过程中,是否因执行DEI政策而违反联邦法律。相关知情人士称,谷歌、威瑞森等多家大型企业已成为调查对象。(央视新闻)

45分钟前

本页详细列出关于九州通的品牌信息,含品牌所属公司介绍,九州通所处行业的品牌地位及优势。
咨询